# FDA Inspection 1254526 - I3 PHARMACEUTICALS LLC - November 22, 2024

Source: https://www.keypedia.com/records/fda_inspections/i3-pharmaceuticals-llc/ce0a316f-34c4-4d5b-aa42-e1ebf6435dc9
Source feed: FDA_Inspections

> FDA Inspection 1254526 for I3 PHARMACEUTICALS LLC on November 22, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1254526
- Company Name: I3 PHARMACEUTICALS LLC
- Inspection Date: 2024-11-22
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1254526 - 2024-11-22](https://www.keypedia.com/records/fda_inspections/i3-pharmaceuticals-llc/fc81d007-fa0f-4b5a-b2ad-b87221c6234d)
- [FDA Inspection 1199801 - 2023-03-03](https://www.keypedia.com/records/fda_inspections/i3-pharmaceuticals-llc/bc8adbc5-8723-4014-bbec-9ab4558f7701)
- [FDA Inspection 1075810 - 2018-12-21](https://www.keypedia.com/records/fda_inspections/i3-pharmaceuticals-llc/c554518c-37c6-4034-98d5-9160adf8f9ca)

Company: https://www.keypedia.com/companies/i3-pharmaceuticals-llc/020702e4-1539-47b8-87d9-725035cecbfe

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c